Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Gains from Investment Securities (2019 - 2026)

Nurix Therapeutics (NRIX) has disclosed Gains from Investment Securities for 8 consecutive years, with $2.7 million as the latest value for Q1 2026.

  • Quarterly Gains from Investment Securities changed N/A to $2.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $35.2 million through Feb 2026, up 270776.92% year-over-year, with the annual reading at $32.5 million for FY2025, 232000.0% up from the prior year.
  • Gains from Investment Securities for Q1 2026 was $2.7 million at Nurix Therapeutics, down from $32.5 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $32.5 million in Q4 2025, with the low at -$26.7 million in Q3 2025.
  • Average Gains from Investment Securities over 5 years is $3.0 million, with a median of $300000.0 recorded in 2024.
  • Peak annual rise in Gains from Investment Securities hit 10731.33% in 2025, while the deepest fall reached 1587.18% in 2025.
  • Over 5 years, Gains from Investment Securities stood at $5.1 million in 2022, then tumbled by 98.54% to $74000.0 in 2023, then skyrocketed by 305.41% to $300000.0 in 2024, then surged by 10731.33% to $32.5 million in 2025, then plummeted by 91.63% to $2.7 million in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $2.7 million, $32.5 million, and -$26.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.